ML261
ML261 is a hepatic lipid droplets formation inhibitor with an IC50 value of 69.7 nM. ML261 can be used for the research of non-alcoholic fatty liver disease (NAFLD) and inflammation[1].
Product Specifications
CAS Number
[902523-58-4]
UNSPSC
12352005
Hazard Statement
H301
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ml261.html
Purity
99.80
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC2=C(C=C(Cl)S2)N1C)NCCC3=CC=C(OCC)C(OCC)=C3
Molecular Formula
C20H23ClN2O3S
Molecular Weight
406.94
Precautions
P264-P270-P330-P405-P501
References & Citations
[1]Zou J, et al. Potent inhibitors of lipid droplet formation. 2014.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6458842-01 0.1 mL
Rnf2 (E3 Ubiquitin-Protein Ligase RING2, 632-, RING Finger Protein 1B, RING1b, RING Finger Protein 2, Rnf2, DinG, Ring1b) (MaxLight 550)
Ask
View Details 
MBS6458842-02 5x 0.1 mL
Rnf2 (E3 Ubiquitin-Protein Ligase RING2, 632-, RING Finger Protein 1B, RING1b, RING Finger Protein 2, Rnf2, DinG, Ring1b) (MaxLight 550)
Ask
View Details 